Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Paolo Verderio"'
Autor:
Serena Di Cosimo, Sara Pizzamiglio, Chiara Maura Ciniselli, Valeria Duroni, Vera Cappelletti, Loris De Cecco, Cinzia De Marco, Marco Silvestri, Maria Carmen De Santis, Andrea Vingiani, Biagio Paolini, Rosaria Orlandi, Marilena Valeria Iorio, Giancarlo Pruneri, Paolo Verderio
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract In clinical trials evaluating antibody-conjugated drugs (ADCs), HER2-low breast cancer is defined through protein immunohistochemistry scoring (IHC) 1+ or 2+ without gene amplification. However, in daily practice, the accuracy of IHC is comp
Externí odkaz:
https://doaj.org/article/d7df224a01ee4e5988733bfc39acbfb0
Autor:
Michele Dei Cas, Chiara Maura Ciniselli, Elisabetta Vergani, Emilio Ciusani, Mariachiara Aloisi, Valeria Duroni, Paolo Verderio, Riccardo Ghidoni, Rita Paroni, Paola Perego, Giovanni Luca Beretta, Laura Gatti, Monica Rodolfo
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 3, p 1558 (2024)
Dysfunctions of lipid metabolism are associated with tumor progression and treatment resistance of cutaneous melanoma. BRAF/MEK inhibitor resistance is linked to alterations of melanoma lipid pathways. We evaluated whether a specific lipid pattern ch
Externí odkaz:
https://doaj.org/article/e6d34927b8cf4d9d9f361f871472e631
Autor:
Iolanda Capone, Fabio Bozzi, Gian Paolo Dagrada, Paolo Verderio, Elena Conca, Adele Busico, Maria Adele Testi, Valentina Monti, Matteo Duca, Claudia Proto, Silvia Damian, Alberta Piccolo, Federica Perrone, Elena Tamborini, Andrea Devecchi, Paola Collini, Daniele Lorenzini, Andrea Vingiani, Luca Agnelli, Giancarlo Pruneri
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 3, Iss 5, Pp 582-597 (2022)
Aim: Diagnostic laboratories are progressively introducing next-generation sequencing (NGS) technologies in the routine workflow to meet the increasing clinical need for comprehensive molecular characterization in cancer patients for diagnosis and pr
Externí odkaz:
https://doaj.org/article/d74b17c328cc45588837b22f3835282c
Autor:
Serena Di Cosimo, Chiara M. Ciniselli, Sara Pizzamiglio, Vera Cappelletti, Marco Silvestri, Sarra El-Abed, Miguel Izquierdo, Mohammed Bajji, Paolo Nuciforo, Jens Huober, David Cameron, Stephen Chia, Henry L. Gomez, Marilena V. Iorio, Andrea Vingiani, Giancarlo Pruneri, Paolo Verderio
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
BackgroundThe absence of breast cancer cells in surgical specimens, i.e., pathological complete response (pCR), is widely recognized as a favorable prognostic factor after neoadjuvant therapy. In contrast, the presence of disease at surgery character
Externí odkaz:
https://doaj.org/article/f0877e2ca68b49758660451e0fb47a28
Autor:
Emanuela Fina, Loredana Cleris, Matteo Dugo, Mara Lecchi, Chiara Maura Ciniselli, Daniele Lecis, Giulia Valeria Bianchi, Paolo Verderio, Maria Grazia Daidone, Vera Cappelletti
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-16 (2022)
Abstract Background Progression to stage IV disease remains the main cause of breast cancer-related deaths. Increasing knowledge on the hematogenous phase of metastasis is key for exploiting the entire window of opportunity to interfere with early di
Externí odkaz:
https://doaj.org/article/049f69f9748246f5b8ea334a7e369741
Autor:
Sara Pizzamiglio, Giulia Cosentino, Chiara M. Ciniselli, Loris De Cecco, Alessandra Cataldo, Ilaria Plantamura, Tiziana Triulzi, Sarra El‐abed, Yingbo Wang, Mohammed Bajji, Paolo Nuciforo, Jens Huober, Susan L. Ellard, David L. Rimm, Andrea Gombos, Maria Grazia Daidone, Paolo Verderio, Elda Tagliabue, Serena Di Cosimo, Marilena V. Iorio
Publikováno v:
Cancer Medicine, Vol 11, Iss 2, Pp 332-339 (2022)
Abstract Background Neoadjuvant therapy with dual HER2 blockade improved pathological complete response (pCR) rate in HER2‐positive breast cancer patients. Nevertheless, it would be desirable to identify patients exquisitely responsive to single ag
Externí odkaz:
https://doaj.org/article/bcbea9275b054d7d92ebc8e572fd0bc6
Autor:
Serena Di Cosimo, Eliana La Rocca, Silva Ljevar, Maria Carmen De Santis, Marta Bini, Vera Cappelletti, Marta Valenti, Paolo Baili, Filippo G. de Braud, Secondo Folli, Gianfranco Scaperrotta, Chiara Volpi, Andrea Vingiani, Claudio Vernieri, Paolo Verderio, Rosalba Miceli, Giancarlo Pruneri
Publikováno v:
Frontiers in Molecular Biosciences, Vol 9 (2022)
Background: Previous data, mostly from clinical trials, reported that HER2-low status is associated with low pathological complete response (pCR), and favourable prognosis. Since these findings suggest the existence of an additional breast cancer sub
Externí odkaz:
https://doaj.org/article/c61dcae8ad024a518f451974ec2c145c
Autor:
Edoardo Zanchetta, Chiara Maura Ciniselli, Annalisa Bardelli, Chiara Colombo, Silvia Stacchiotti, Giacomo Giulio Baldi, Salvatore Provenzano, Rossella Bertulli, Federica Bini, Alessandra Casale, Francesca Gabriella Greco, Andrea Ferrari, Paolo Verderio, Marco Fiore, Alessandro Gronchi, Paolo Giovanni Casali, Carlo Morosi, Elena Palassini
Publikováno v:
Cancer Medicine, Vol 10, Iss 13, Pp 4356-4365 (2021)
Abstract Background We aimed to investigate changes in volume and MRI T2‐weighted intensity in desmoid‐type fibromatosis (DF) receiving methotrexate plus vinca‐alkaloids (MTX‐VA) at Istituto Nazionale dei Tumori, Milan. Methods All cases of s
Externí odkaz:
https://doaj.org/article/f3e29b4f3feb4f96ace7829a48911c86
Autor:
Giovanni Fucà, Mara Lecchi, Chiara Maura Ciniselli, Arianna Ottini, Andrea Spagnoletti, Laura Mazzeo, Daniele Morelli, Paola Frati, Martina Stroscia, Elisabella Ebrahem, Elisa Sottotetti, Giulia Galli, Maria Grazia D’Elia, Riccardo Lobefaro, Monika Ducceschi, Lorenza Di Guardo, Sherrie Bhoori, Salvatore Provenzano, Marco Platania, Monica Niger, Elena Colombo, Federico Nichetti, Matteo Duca, Licia Rivoltini, Roberta Mortarini, Paolo Baili, Giovanni Apolone, Filippo de Braud, Paolo Verderio, Silvia Damian
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: Systemic immunosuppression characterizing cancer patients represents a concern regarding the efficacy of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, and real-world evidence is needed to define the effica
Externí odkaz:
https://doaj.org/article/f05777205f62491487f8dae093b20afa
Autor:
Mara Lecchi, Paolo Verderio, Vera Cappelletti, Francesca De Santis, Biagio Paolini, Melissa Monica, Sabina Sangaletti, Serenella Maria Pupa, Marilena Valeria Iorio, Giulia Bianchi, Massimiliano Gennaro, Giovanni Fucà, Filippo De Braud, Elda Tagliabue, Massimo Di Nicola
Publikováno v:
Molecular Oncology, Vol 15, Iss 5, Pp 1345-1357 (2021)
Breast cancer (BC) is a heterogeneous disease in which the tumor microenvironment (TME) seems to impact the clinical outcome. Here, we investigated whether a combination of gene expression signatures relating to both the structural and immune TME asp
Externí odkaz:
https://doaj.org/article/4545c7dc97c346a6b97352acf707038d